 The reality is drug shortages impact our business every bit as much as they do anybody else's within the supply chain. We want medicines moving. We want product shelves filled in order to be able to do what we do on behalf of our trading partners and ultimately patients. So we source multiple providers and increasingly are looking at things beyond cost, such as their resiliency, their historical track record, their ability to meet demand.